@article{Rausch_Dzama_Dolgikh_Stiller_Bohl_Lahrmann_Kunz_Kessler_Echchannaoui_Chen_Kindler_Döhner_Burrows_Theobald_Sasca_Kühn_2023, place={Pavia, Italy}, title={Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with <i>MLL</i> rearrangement or <i>NPM1</i&gt; mutation to venetoclax}, volume={108}, url={https://haematologica.org/article/view/haematol.2022.282160}, DOI={10.3324/haematol.2022.282160}, number={10}, journal={Haematologica}, author={Rausch, Johanna and Dzama, Margarita M. and Dolgikh, Nadezda and Stiller, Hanna L. and Bohl, Stephan R. and Lahrmann, Catharina and Kunz, Kerstin and Kessler, Linda and Echchannaoui, Hakim and Chen, Chun-Wei and Kindler, Thomas and Döhner, Konstanze and Burrows, Francis and Theobald, Matthias and Sasca, Daniel and Kühn, Michael W.M.}, year={2023}, month={Oct.}, pages={2837-2843} }